An association between Vogt-Koyanagi-Harada disease and Guillain-Barré syndrome

Najman-Vainer, Jacobo; Levinson, Ralph D.; Graves, Michael C.; Nguyen, B.V.; Engstrom, Robert E.; Holland, Gary N.

doi:10.1016/s0002-9394(01)00958-8

Cited by 22 publications

(9 citation statements)

References 19 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Cases of the syndrome have also been reported in patients with malignant lymphoma 25 and patients with chronic hepatitis C who were taking interferon-alpha and ribavirin 26 . Several other autoimmune diseases may be associated with VKHS, such as Graves' disease 27 , IgA nephropathy 28 , polyglandular autoimmune syndrome type I 29 , recurrent polychondritis 30 , aortitis 31 , Guillain-Barré syndrome 32 , Diabetes mellitus 33 and scleroderma 34 .…”

Section: Etiology and Pathogenesismentioning

confidence: 99%

Síndrome de Vogt-Koyanagi-Harada e o seu acometimento multissistêmico

Mota¹,

Santos²

2010

Rev. Assoc. Med. Bras.

View full text Add to dashboard Cite

Vogt-Koyanagi-Harada's syndrome is a rare disease that affects tissues containing melanocytes, such as the eyes, central nervous system, inner ear and skin. Some ethnic groups have a higher probability of developing the disease, including Asians, Indians and Latin Americans and females are affected more often. Methods: Literature was reviewed in books, articles published on the internet and papers available in the online databases MEDLINE, LILACS and SciELO. Texts were selected that focused on otorhinolaryngological symptoms. Literature review: The disease probably has autoimmune etiology, with aggression occurring on the surface of melanocytes by promoting inflammatory reaction in which T lymphocytes predominate. The allele most often found in association with this disease is HLA DRB1*0405. Clinical manifestations are divided into four stages: prodromal, uveitic, chronic and recurrent. Otorhinolaryngological symptoms occur during the uveitic stage and are characterized by bilateral sensorineural hearing loss, tinnitus and vestibular symptoms. Diagnosis is made according to the diagnostic criteria for the disease. Treatment is primarily with corticosteroids. Conclusions: It is important that professionals in other specialties are able to recognize Vogt-Koyanagi-Harada's syndrome, because late diagnosis can lead to ocular and cutaneous sequelae.

show abstract

Section: Etiology and Pathogenesismentioning

confidence: 99%

Síndrome de Vogt-Koyanagi-Harada e o seu acometimento multissistêmico

Mota¹,

Santos²

2010

Rev. Assoc. Med. Bras.

View full text Add to dashboard Cite

show abstract

“…7 GBS is considered to be an autoimmune disease triggered by a preceding bacterial or viral infection. 10 In our opinion, the evidence for olanzapine directly causing our patient's condition is strong. 9 The association of GBS and Vogt-Koyanagi-Harada disease has been previously described in 3 cases.…”

Section: Discussionmentioning

confidence: 62%

“…6 It has been suggested that individual patient differences in metabolism involving N-acetylation and oxidation may result in the accumulation of potentially toxic substances in a similar fashion. 10 Notwithstanding, in these cases, neither rash nor liver abnormalities were present, and no medication was started prior to the onset of GBS. 8 This condition has been linked to several drugs, but a drug-induced hypersensitivity reaction causing GBS is rare.…”

Section: Discussionmentioning

confidence: 86%

Guillain-Barré-like Syndrome Associated With Olanzapine Hypersensitivity Reaction

Benito‐León

Mitchell²

2005

Clinical Neuropharmacology

View full text Add to dashboard Cite

Olanzapine is the most commonly prescribed atypical antipsychotic drug. Recently there has been increased concern over possible adverse metabolic effects of this drug. The authors describe the first case of Guillain-Barré-like syndrome associated with an olanzapine hypersensitivity reaction. The presence of progressive numbness, motor weakness, or pain in the limbs of patients receiving olanzapine should raise suspicion of Guillain-Barré syndrome.

show abstract

“…8 There are a few case presentations in the literature reporting total ophthalmoplegia, optic nerve involvement, ptosis, Vogt-Koyanagi-Harada, and uveitis as ocular findings of GBS. 9,10,11,12 …”

Section: Introductionmentioning

confidence: 99%

Possible Association of Papillophlebitis with Guillain-Barré Syndrome: Case Report

Karataş

Soylu

2018

tjo

View full text Add to dashboard Cite

In this case report, we presented a patient with visual deterioration as a result of papillophlebitis in the right eye who was later diagnosed with Guillain-Barré syndrome (GBS). Upon systemic and laboratory work-up to determine the etiology of papillophlebitis, the diagnosis of GBS was made and treatment was initiated immediately. The ocular and systemic symptoms resolved quickly after starting intravenous immunoglobulin therapy. We present this case to emphasize the importance of etiological diagnosis in papillophlebitis and the unusual presentation of GBS.

show abstract

An association between Vogt-Koyanagi-Harada disease and Guillain-Barré syndrome

Cited by 22 publications

References 19 publications

Síndrome de Vogt-Koyanagi-Harada e o seu acometimento multissistêmico

Síndrome de Vogt-Koyanagi-Harada e o seu acometimento multissistêmico

Guillain-Barré-like Syndrome Associated With Olanzapine Hypersensitivity Reaction

Possible Association of Papillophlebitis with Guillain-Barré Syndrome: Case Report

Contact Info

Product

Resources

About